Esclibano, Eliza Grace .

HRN: 27-58-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
CEFTAZIDIME 1GM (VIAL)
08/03/2025
08/10/2025
IV
1.5g
Q12h
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: